FMR LLC lowered its holdings in Colgate-Palmolive (NYSE:CL) by 18.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,719,256 shares of the company’s stock after selling 1,325,794 shares during the quarter. FMR LLC owned 0.66% of Colgate-Palmolive worth $340,412,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Janus Henderson Group PLC raised its position in Colgate-Palmolive by 16.6% during the third quarter. Janus Henderson Group PLC now owns 461,370 shares of the company’s stock worth $30,888,000 after acquiring an additional 65,628 shares during the period. Bank of New York Mellon Corp grew its holdings in shares of Colgate-Palmolive by 1.1% during the third quarter. Bank of New York Mellon Corp now owns 20,359,199 shares of the company’s stock worth $1,363,050,000 after buying an additional 223,814 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Colgate-Palmolive by 0.6% during the third quarter. Dimensional Fund Advisors LP now owns 1,679,771 shares of the company’s stock worth $112,456,000 after buying an additional 10,209 shares in the last quarter. Baird Financial Group Inc. grew its holdings in shares of Colgate-Palmolive by 9.1% during the third quarter. Baird Financial Group Inc. now owns 44,450 shares of the company’s stock worth $2,981,000 after buying an additional 3,726 shares in the last quarter. Finally, Standard Life Aberdeen plc grew its holdings in shares of Colgate-Palmolive by 5.0% during the third quarter. Standard Life Aberdeen plc now owns 345,470 shares of the company’s stock worth $23,130,000 after buying an additional 16,446 shares in the last quarter. 76.22% of the stock is currently owned by hedge funds and other institutional investors.
Shares of CL traded up $2.61 during mid-day trading on Friday, reaching $71.30. 5,689,727 shares of the company’s stock were exchanged, compared to its average volume of 3,843,177. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $71.50. The company has a current ratio of 1.14, a quick ratio of 0.76 and a debt-to-equity ratio of 32.25. The firm has a market cap of $59.34 billion, a PE ratio of 24.01, a price-to-earnings-growth ratio of 4.53 and a beta of 0.79.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a $0.43 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. The ex-dividend date is Wednesday, April 17th. This represents a $1.72 annualized dividend and a yield of 2.41%. Colgate-Palmolive’s payout ratio is presently 57.91%.
In other Colgate-Palmolive news, Director John T. Cahill sold 5,780 shares of Colgate-Palmolive stock in a transaction dated Thursday, January 31st. The stock was sold at an average price of $64.46, for a total value of $372,578.80. Following the completion of the sale, the director now owns 27,820 shares in the company, valued at approximately $1,793,277.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Ian M. Cook sold 22,634 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 19th. The shares were sold at an average price of $66.31, for a total value of $1,500,860.54. Following the completion of the sale, the chief executive officer now owns 1,162,793 shares of the company’s stock, valued at approximately $77,104,803.83. The disclosure for this sale can be found here. Insiders sold a total of 103,200 shares of company stock valued at $6,900,449 in the last three months. 1.14% of the stock is currently owned by corporate insiders.
A number of equities research analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Tuesday. UBS Group upped their price objective on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the company a “buy” rating in a report on Friday, March 29th. Citigroup set a $68.00 target price on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research note on Tuesday, March 19th. Credit Suisse Group initiated coverage on shares of Colgate-Palmolive in a research note on Wednesday, March 6th. They set an “underperform” rating for the company. Finally, BNP Paribas raised shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and increased their target price for the stock from $56.00 to $67.00 in a research note on Monday, February 11th. Three research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $65.73.
TRADEMARK VIOLATION NOTICE: This news story was originally posted by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://www.baseballdailydigest.com/news/2019/04/26/colgate-palmolive-cl-stake-lessened-by-fmr-llc.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Further Reading: What is the LIBOR?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.